[Prostatic adenoma: new drugs, new surgical techniques].
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000736:Androstenes / Q000627:therapeutic use*; D001378:Azasteroids / Q000627:therapeutic use*; D020684:Cystoscopes; D017292:Doxazosin / Q000627:therapeutic use*; D018120:Finasteride; D006801:Humans; D008297:Male; D011224:Prazosin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011468:Prostatectomy / Q000295:instrumentation*; D011470:Prostatic Hyperplasia / Q000188:drug therapy* / Q000601:surgery; D015607:Stents
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists; D000736:Androstenes; D001378:Azasteroids; D018120:Finasteride; C041226:Terazosin; D017292:Doxazosin; D011224:Prazosin
Prostataadenom: Neue Arzneimittel, neue Operationstechniken.